These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 18774720)

  • 81. Homologous down-regulation of histamine H3 receptors in rat striatal slices.
    Garduño-Torres B; Arias-Montaño JA
    Synapse; 2006 Aug; 60(2):165-71. PubMed ID: 16715497
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Comparison of the pharmacological properties of human and rat histamine H(3)-receptors.
    Schnell D; Strasser A; Seifert R
    Biochem Pharmacol; 2010 Nov; 80(9):1437-49. PubMed ID: 20688049
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Molecular basis for the selective interaction of synthetic agonists with the human histamine H1-receptor compared with the guinea pig H1-receptor.
    Strasser A; Wittmann HJ; Kunze M; Elz S; Seifert R
    Mol Pharmacol; 2009 Mar; 75(3):454-65. PubMed ID: 19047480
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Synthesis of specific bivalent probes that functionally interact with 5-HT(4) receptor dimers.
    Russo O; Berthouze M; Giner M; Soulier JL; Rivail L; Sicsic S; Lezoualc'h F; Jockers R; Berque-Bestel I
    J Med Chem; 2007 Sep; 50(18):4482-92. PubMed ID: 17676726
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Multiple enzyme inhibitions by histamine H3 receptor antagonists as potential procognitive agents.
    Petroianu G; Arafat K; Sasse BC; Stark H
    Pharmazie; 2006 Mar; 61(3):179-82. PubMed ID: 16599255
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Dibasic non-imidazole histamine H3 receptor antagonists with a rigid biphenyl scaffold.
    Morini G; Comini M; Rivara M; Rivara S; Lorenzi S; Bordi F; Mor M; Flammini L; Bertoni S; Ballabeni V; Barocelli E; Plazzi PV
    Bioorg Med Chem Lett; 2006 Aug; 16(15):4063-7. PubMed ID: 16713264
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Detailed pharmacological characterization of GT-2331 for the rat histamine H3 receptor.
    Ito S; Yoshimoto R; Miyamoto Y; Mitobe Y; Nakamura T; Ishihara A; MacNeil DJ; Kanatani A; Tokita S
    Eur J Pharmacol; 2006 Jan; 529(1-3):40-6. PubMed ID: 16316645
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands.
    Markl C; Attia MI; Julius J; Sethi S; Witt-Enderby PA; Zlotos DP
    Bioorg Med Chem; 2009 Jul; 17(13):4583-94. PubMed ID: 19473848
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
    Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
    Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Synthesis and three-dimensional quantitative structure-activity relationship analysis of H3 receptor antagonists containing a neutral heterocyclic polar group.
    Rivara S; Mor M; Bordi F; Silva C; Zuliani V; Vacondio F; Morini G; Plazzi PV; Carrupt PA; Testa B
    Drug Des Discov; 2003; 18(2-3):65-79. PubMed ID: 14675944
    [TBL] [Abstract][Full Text] [Related]  

  • 91. D-amino acid homopiperazine amides: discovery of A-320436, a potent and selective non-imidazole histamine H(3)-receptor antagonist.
    Curtis MP; Dwight W; Pratt J; Cowart M; Esbenshade TA; Krueger KM; Fox GB; Pan JB; Pagano TG; Hancock AA; Faghih R; Bennani YL
    Arch Pharm (Weinheim); 2004 Apr; 337(4):219-29. PubMed ID: 15146898
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Use of novel, non-imidazole inverse agonist radioligands to define histamine H3 receptor pharmacology.
    Esbenshade TA; Yao BB; Witte DG; Carr TL; Sharma R; Baranowski JL; Krueger KM; Miller TR; Surber BW; Faghih R; Hancock AA
    Inflamm Res; 2005 Apr; 54 Suppl 1():S46-7. PubMed ID: 15928830
    [No Abstract]   [Full Text] [Related]  

  • 93. Synthesis, biological activity and molecular modelling of new trisubstituted 8-azaadenines with high affinity for A1 adenosine receptors.
    Giorgi I; Bianucci AM; Biagi G; Livi O; Scartoni V; Leonardi M; Pietra D; Coi A; Massarelli I; Nofal FA; Fiamingo FL; Anastasi P; Giannini G
    Eur J Med Chem; 2007 Jan; 42(1):1-9. PubMed ID: 17028066
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Development of a selective and potent radioactive ligand for histamine H(3) receptors: A compound potentially useful for receptor occupancy studies.
    Mitobe Y; Ito S; Mizutani T; Nagase T; Sato N; Tokita S
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4075-8. PubMed ID: 19553110
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptor.
    Rivara M; Vacondio F; Silva C; Zuliani V; Fantini M; Bordi F; Plazzi PV; Bertoni S; Ballabeni V; Flammini L; Barocelli E; Mor M
    Chem Biodivers; 2008 Jan; 5(1):140-52. PubMed ID: 18205116
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Synthesis of chiral 1-[omega-(4-chlorophenoxy)alkyl]-4-methylpiperidines and their biological evaluation at sigma1, sigma2, and sterol delta8-delta7 isomerase sites.
    Berardi F; Loiodice F; Fracchiolla G; Colabufo NA; Perrone R; Tortorella V
    J Med Chem; 2003 May; 46(11):2117-24. PubMed ID: 12747784
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Influence of bulky substituents on histamine h(3) receptor agonist/antagonist properties.
    Sasse A; Ligneau X; Rouleau A; Elz S; Ganellin CR; Arrang JM; Schwartz JC; Schunack W; Stark H
    J Med Chem; 2002 Aug; 45(18):4000-10. PubMed ID: 12190321
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Synthesis of heteroarylpiperazines and heteroarylbipiperidines with a restricted side chain and their affinities for 5-HT1A receptor.
    Yoo KH; Choi HS; Kim DC; Shin KJ; Kim DJ; Song YS; Jin C
    Arch Pharm (Weinheim); 2003 Jul; 336(4-5):208-15. PubMed ID: 12916054
    [TBL] [Abstract][Full Text] [Related]  

  • 99. 2-[(4-phenylpiperazin-1-yl)methyl]imidazo(di)azines as selective D4-ligands. Induction of penile erection by 2-[4-(2-methoxyphenyl)piperazin-1-ylmethyl]imidazo[1,2-a]pyridine (PIP3EA), a potent and selective D4 partial agonist.
    Enguehard-Gueiffier C; Hübner H; El Hakmaoui A; Allouchi H; Gmeiner P; Argiolas A; Melis MR; Gueiffier A
    J Med Chem; 2006 Jun; 49(13):3938-47. PubMed ID: 16789750
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Use of an inverse agonist radioligand [3H]A-317920 reveals distinct pharmacological profiles of the rat histamine H3 receptor.
    Yao BB; Witte DG; Miller TR; Carr TL; Kang CH; Cassar S; Faghih R; Bennani YL; Surber BW; Hancock AA; Esbenshade TA
    Neuropharmacology; 2006 Mar; 50(4):468-78. PubMed ID: 16316670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.